Latest news with #MaxHealthcareInstitute
&w=3840&q=100)
Business Standard
a day ago
- Business
- Business Standard
Narayana, Max Healthcare shares gain up to 5%, hit new highs in weak market
Shares of hospitals and healthcare services providers were in demand, and rallied up to 5 per cent on the BSE in Friday's intra-day trade in an otherwise weak market on the back of a healthy outlook. Shares of Narayana Hrudayalaya hit a new high of ₹1,906.15, surging 5 per cent on the BSE in intra-day trade. The stock surpassed its previous high of ₹1,872.85 touched on April 21, 2025. The share price of Max Healthcare Institute also hit a new high of ₹1,234.70, gaining 3 per cent in intra-day trade. It surpassed its earlier high of ₹1,227.50 touched on January 8, 2025. Thyrocare Technologies (up 5 per cent at ₹1,028.90) and Krishna Institute of Medical Sciences or KIMS (up 3 per cent at ₹683.05) were up in the range of 3 per cent and 5 per cent. In comparison, the BSE Sensex was down 0.73 per cent at 81,096 at 02:01 PM. Most Indian hospitals have now broken even and started contributing to profits. There is a rising demand for specialized treatments, including oncology and high-end surgical procedures. This trend is contributing to higher ARPOB (Average Revenue per Occupied Bed) and overall revenue growth. According to analysts at Choice Equity Broking, accounting for ~5-7 per cent of revenue, medical tourism is expected to grow at nearly double the overall rate in the mid-term. Factors such as normalization in the geo-political issue, operationalization of a new airport in Noida, affordable treatment costs, world-class facilities, and skilled medical personnel will continue to attract international patients, particularly from Southeast Asia and the Middle East, analysts said. Meanwhile, India's healthcare sector is on the cusp of significant transformation, driven by increased public and private investments, policy initiatives, and demographic shifts. Despite the current challenges, including disparities in healthcare infrastructure and the availability of medical services in the workforce between urban and rural areas, the future looks promising with sustained efforts and strategic investments. As of 2022, India's healthcare spending accounted for 3.3 per cent of the GDP; however, with sustained efforts, it is anticipated to reach 5 per cent by 2030, according to CareEdge Ratings. Looking forward, the rising share of the population aged over 45 years, coupled with income growth, is also expected to catalyse higher demand for quality healthcare services. This demand will likely translate into sustained investments across the entire value chain, from medical education and training to hospital infrastructure and digital healthcare technologies, the rating agency said. As per latest available data from National Health Accounts (NHA), government healthcare spending has increased significantly in recent years. The government health expenditure (GHE) as a percentage of GDP grew from ~1.1 per cent in FY15 to ~1.8 per cent in FY22. Similarly, its share within the general government expenditure (GGE) saw a notable rise, climbing from ~3.9 per cent in FY15 to ~6.1 per cent in FY22. GHE as a percentage of total health expenditure (THE) grew from 40.8 per cent in FY18 to 48.0 per cent in FY22, demonstrating a shift toward government-funded healthcare. These trends highlight the government's growing commitment to strengthening the healthcare sector. Furthermore, per capita government health expenditure rose from ₹ 1,753 in FY18 to ₹ 3,169 in FY22 at a 16 per cent CAGR, indicating increased spending on healthcare services per individual, analysts at Elara Capital said in the Health Insurance sector update.
Business Standard
21-05-2025
- Business
- Business Standard
Max Healthcare Institute consolidated net profit rises 26.82% in the March 2025 quarter
Sales rise 34.21% to Rs 1909.74 crore Net profit of Max Healthcare Institute rose 26.82% to Rs 319.00 crore in the quarter ended March 2025 as against Rs 251.54 crore during the previous quarter ended March 2024. Sales rose 34.21% to Rs 1909.74 crore in the quarter ended March 2025 as against Rs 1422.90 crore during the previous quarter ended March 2024. For the full year,net profit rose 1.72% to Rs 1075.88 crore in the year ended March 2025 as against Rs 1057.64 crore during the previous year ended March 2024. Sales rose 30.01% to Rs 7028.46 crore in the year ended March 2025 as against Rs 5406.02 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 1909.741422.90 34 7028.465406.02 30 OPM % 26.7926.81 - 26.3027.60 - PBDT 503.33406.05 24 1839.421610.30 14 PBT 402.50335.73 20 1480.001365.32 8 NP 319.00251.54 27 1075.881057.64 2
Time of India
20-05-2025
- Business
- Time of India
Max Hits ₹9,000 Cr in FY25, Q4 revenue soars 29% on higher bed occupancy
Mumbai: Corporate Hospital chain, Max Healthcare Institute Q4 FY2024-25 revenue reported a growth of 29 per cent to ₹2,429 crore, up against ₹1,888 crore from the year ago quarter. For the January-March quarter the hospital's net profit went up 21 per cent to ₹376 crore, against the previous year figures of ₹311 crore while the earnings before interest and taxes (EBITDA) stood at ₹632 crore. The hospitals bed occupancy for the quarter was at 75 per cent, with a 30 per cent increase in bed occupied days (BOD) ad the ARPOB (Average Revenue Per Occupied Bed) stood at ₹77.1 thousand, up against ₹76.8 thousand reported in the year ago period. Overall EBITDA per bed was ₹ 73.9 lakhs compared to ₹76 lakhs in Q4 FY24 and the share of revenue from new units stood at 15 per cent compared to 2 per cent in the year ago period. During the period Max entered into a Long-term Service Agreement to sett up a 200-bed hospital in Pitampura, Delhi in association with Bharat Prakritik Chikitsa Mission. 'We have reported the 18th consecutive quarter of year-on-year growth in both Revenue and Operating EBITDA — a testament to the strength of our operating model, in Q4 we took significant strategic steps for long-term growth, including corporate actions and two M&A transactions,' said Abhay Soi, Chairman and Managing Director, Max Healthcare Institute Ltd. For the full financial year Max gross revenue went up 26 per cent YoY to ₹9,065 crore, while the net profit went up 9 per cent to ₹1,392 crore , attributed with the 'increase in OBDs.' Outlining the company's future plans, Soi said, 'We are commencing operations at our three new brownfield towers in Saket, Nanavati, and Mohali in the next three months and will add 1,500 beds to our capacity in the current financial year.' Recently while inaugurating its Dwarka-based 300-bed super speciality facility, Soi had voiced that, the company will invest '₹6,000 crore by 2028 to add 3,700 beds across key locations in India." Currently the hospital chain operates a network of 22 hospitals with a total strenth of around 5000 beds and caters to more than 30 specialities.
&w=3840&q=100)
Business Standard
20-05-2025
- Business
- Business Standard
Max Healthcare Q4 net profit rises 26.8% to Rs 319 crore, revenue up 32%
Max Healthcare Institute on Tuesday reported a 26.8 per cent year-on-year (Y-o-Y) rise in consolidated net profit in the March quarter of financial year 2024–25 (Q4 FY25) to Rs 319 crore, up from Rs 251.54 crore reported in the same quarter last year. The New Delhi-based hospital chain's revenue from operations rose to Rs 1,909.74 crore, a 32 per cent Y-o-Y rise from Rs 1,422.90 crore in Q4 FY24. Sequentially, the company's net profit rose by 33.8 per cent, while revenue grew marginally by 2 per cent from Rs 238.80 crore and Rs 1,868.31 crore recorded in Q3 FY25, respectively. The company has earlier stated that three of its partner healthcare facilities in New Delhi — Max Balaji Hospital, Max Smart Super Speciality Hospital and Max Saket Super Speciality Hospital — are not included in consolidated financial statements. If the three facilities are considered, revenue for the whole entity stands at Rs 2,302 crore, and net profit would be Rs 376 crore, according to the company's investor presentation. The on-year rise in revenue was attributed to a rise in occupied bed capacity at new facilities and a subsequent increase in the average revenue per occupied bed (Arpob) per day. In the March quarter, Max Healthcare saw its operational bed capacity go up by 188 beds, mainly at Lucknow, Dwarka and BLK Max Hospitals. 'Overall occupancy stood at 75 per cent, with occupied bed days (OBDs) growing by 30 per cent on-year,' the company said. The company's Arpob per OBD also stood at Rs 77,100, up from Rs 76,800 in Q4 FY24. It also saw a 28 per cent year-on-year increase in international patient revenue to Rs 202 crore in Q4 FY25, comprising nearly 9 per cent of the hospital's revenue. Abhay Soi, chairman and managing director, Max Healthcare, said that the company took strategic steps in Q4 to position it for long-term growth, including corporate actions and two M&A transactions. This includes execution of a long-term service agreement to establish a 200-bed hospital in north-west Delhi and a sale deed for the purchase of a one-acre land parcel, along with the Max Super Speciality Hospital in Uttar Pradesh's Vaishali building. 'The property is adjoining the existing hospital premises and will enable brownfield expansion of the hospital's capacity from 387 beds to 527 beds, within the next 30 months,' Max stated in a regulatory filing. Soi added that the company will also be commencing operations at three new brownfield towers in Saket, Nanavati and Mohali hospitals in the next three months. On the company's expansion plans, Soi had previously told Business Standard that Max is looking to expand bed capacity by at least 1,500, or 30 per cent of its current size, reaching around 6,500 beds, in the ongoing financial year 2025–26 (FY26).
Yahoo
30-04-2025
- Business
- Yahoo
Max Healthcare Institute aims to add 3,700 beds by 2028
Max Healthcare Institute has announced plans to invest Rs60bn ($708.25m) by 2028 to expand its presence in India with 3,700 beds, as reported by PTI, citing chairman and managing director Abhay Soi. The investment is set to increase the company's capacity, which currently offers nearly 5,000 beds across 22 healthcare facilities. This expansion will potentially bring the total number of Max Healthcare hospitals to approximately 30 by 2028. The company's intention of reinvesting the revenue it generates over the next decade into healthcare asset creation was announced at the opening of the 300-bed Max Super Speciality Hospital in Dwarka, a greenfield facility. Soi said: "This year alone, we are opening four [hospitals]. This [Dwarka] was the first of the four." Later this year, three additional hospitals are expected to open in Mohali, Mumbai, and Saket, New Delhi. The expansion strategy includes both the construction of new hospitals and the enlargement of existing ones. For overall expansion, the investment will be allocated through internal funding while all profits will be reinvested into creating new hospital beds. Regarding future acquisitions, Soi stated that while the company is open to opportunities, the budget for such acquisitions would be separate from the funds allocated for organic growth. The new Dwarka facility has more than 120 critical care beds, ten operation theatres, and Cath Labs, offering tertiary and quaternary care across various specialities. These encompass neurosciences, robotic surgery, cardiac sciences, oncology, renal sciences, paediatrics, and organ transplants. Considered a critical hub for enhanced medical care, Delhi-NCR stands to benefit from this expansion. The Dwarka hospital's strategic location aims to address the region's growing healthcare requirements. On 12 November 2024, Max Healthcare Institute saw its shares rise by up to 4% following the completion of its acquisition of Jaypee Hospital. "Max Healthcare Institute aims to add 3,700 beds by 2028" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
